Corticotrophins, corticosteroids, and prostaglandins

Fardet, 2007, Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion, Br J Dermatol, 157, 142, 10.1111/j.1365-2133.2007.07950.x Mathis, 2007, Retrospective analysis of early steroid-induced adverse reactions in kidney and kidney–pancreas transplant recipients, Transplant Proc, 39, 199, 10.1016/j.transproceed.2006.10.011 Wood-Baker, 2007, Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews, Respir Med, 101, 371, 10.1016/j.rmed.2006.07.013 Bendahhou, 2007, Corticosteroid-exacerbated symptoms in an Andersen’s syndrome kindred, Hum Mol Genet, 16, 900, 10.1093/hmg/ddm034 Akikusa, 2007, Sinus bradycardia after intravenous pulse methylprednisolone, Pediatrics, 119, e778, 10.1542/peds.2006-0029 Varas-Lorenzo, 2007, Use of oral corticosteroids and the risk of acute myocardial infarction, Atherosclerosis, 192, 376, 10.1016/j.atherosclerosis.2006.05.019 Ribichini, 2007, Neutropenia in patients treated with thienopyridines and high-dose oral prednisone after percutaneous coronary interventions, J Interv Cardiol, 20, 209, 10.1111/j.1540-8183.2007.00256.x Irvin, 2007, Dexamethasone-induced posterior reversible encephalopathy syndrome, J Clin Oncol, 25, 2484, 10.1200/JCO.2007.10.9991 Lee, 2007, Postoperative infectious endophthalmitis after triamcinolone-assisted anterior vitrectomy, J Cataract Refract Surg, 33, 731, 10.1016/j.jcrs.2006.10.071 Miyai, 2007, Interlamellar flap edema due to steroid-induced ocular hypertension after laser in situ keratomileusis, Jpn J Ophthalmol, 51, 228, 10.1007/s10384-006-0441-y Fardet, 2007, Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome, Rheumatology, 46, 1102, 10.1093/rheumatology/kem062 Uzu, 2007, Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases, Nephron Clin Pract, 105, c54, 10.1159/000097598 Le Moli, 2007, Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves’ ophthalmopathy, Thyroid, 17, 357, 10.1089/thy.2006.0267 Lee, 2007, Pericentral liver cell necrosis associated with the use of high-dose intravenous methylprednisolone, Dig Dis Sci, 52, 1533, 10.1007/s10620-006-9569-3 Matsumoto, 2007, Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatitis, Pathol Int, 57, 388, 10.1111/j.1440-1827.2007.02112.x Toshiharu, 2007, Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatitis, Pathol Int, 57, 388, 10.1111/j.1440-1827.2007.02112.x Goss, 2007, Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment, Br J Dermatol, 156, 582, 10.1111/j.1365-2133.2006.07668.x Huang, 2007, Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate, J Am Acad Dermatol, 57, S81, 10.1016/j.jaad.2006.05.070 Gourlay, 2007, Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures, Clin Rheumatol, 26, 144, 10.1007/s10067-006-0315-1 De Vries, 2007, Fracture risk with intermittent high-dose oral glucocorticoid therapy, Arthritis Rheum, 56, 208, 10.1002/art.22294 Weinstein, 2007, Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures?, Nat Clin Pract Endocrinol Metab, 3, 86, 10.1038/ncpendmet0372 Bell, 2007, Persistent sexual arousal in a woman with associated cardiac defects and raised atrial natriuretic peptide, Int J STD AIDS, 18, 130, 10.1258/095646207779949592 Yi, 2007, Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation, Liver Transplant, 13, 451, 10.1002/lt.21043 Nausheen, 2007, Q fever community-acquired pneumonia in a patient with Crohn’s disease on immunosuppressive therapy, Heart Lung, 36, 300, 10.1016/j.hrtlng.2007.02.010 Silvano, 2007, Herpes simplex virus-1 fatal encephalitis following chemo-radiotherapy, steroids and prophylactic cranial irradiation in a small cell lung cancer patient, Lung Cancer, 57, 243, 10.1016/j.lungcan.2007.01.031 Maronn, 2007, Pneumocystis carinii pneumonia in infant treated with oral steroids for hemangioma, Arch Dermatol, 143, 1224, 10.1001/archderm.143.9.1224 Patel, 2007, Gene–drug interaction at the glucocorticoid receptor increases risk of squamous cell skin cancer, J Invest Dermatol, 127, 1868, 10.1038/sj.jid.5700798 Carmichael, 2007, Maternal corticosteroid use and orofacial clefts, Am J Obs Gynecol, 197, 585, 10.1016/j.ajog.2007.05.046 Halverstam, 2007, Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome, Pediatr Dermatol, 24, 42, 10.1111/j.1525-1470.2007.00331.x Williams, 2007, Established corticosteroid creams should be applied only once daily in patients with atopic eczema, BMJ, 334, 1272, 10.1136/bmj.39195.636319.80 Talosi, 2007, Side-effects of long-term prostaglandin E1 treatment in neonates, Pediatr Int, 49, 335, 10.1111/j.1442-200X.2007.02380.x Estes, 2007, Cortical hyperostosis secondary to prostaglandin E1 therapy, J Pediatr, 151, 441, 10.1016/j.jpeds.2007.02.066 Sharpe, 2007, The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy, Curr Eye Res, 32, 1037, 10.1080/02713680701750625 Dursun, 2007, Iloprost-induced sudden hearing loss, J Laryngol Otol, 121, 609, 10.1017/S0022215107006858 Horgan, 2007, Choroidal detachment associated with latanoprost use in the fellow eye, Ann Pharmacother, 41, 161, 10.1345/aph.1H548 Arranz-Marquez, 2007, Effect of age on the development of a latanoprost-induced increase in iris pigmentation, Ophthalmology, 114, 1255, 10.1016/j.ophtha.2006.10.042 Kathryn, 2007, Morphometric effects of long-term exposure to latanoprost, Ophthalmology, 114, 938, 10.1016/j.ophtha.2006.10.025 Filippini, 2007, Acute hemolytic anemia with acanthocytosis associated with high-dose misoprostol for medical abortion, Ann Emerg Med, 50, 289, 10.1016/j.annemergmed.2006.09.001 Khan, 2007, Uterine rupture at 8 weeks’ gestation following 600 μg of oral misoprostol for management of delayed miscarriage, J Obstet Gynaecol, 27, 869, 10.1080/01443610701788514 Rosa, 2007, Poland syndrome associated with an aberrant subclavian artery and vascular abnormalities of the retina in a child exposed to misoprostol during pregnancy, Birth Defects Res A Clin Mol Teratol, 79, 507, 10.1002/bdra.20366 Henriques, 2007, Maternal death related to misoprostol overdose, Obstet Gynecol, 109, 489, 10.1097/01.AOG.0000253248.64065.94 Aydin, 2007, Corneal oedema and acute anterior uveitis after two doses of travoprost, Acta Ophthalmol Scand, 85, 693, 10.1111/j.1600-0420.2007.00922.x Feletti, 2007, Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes, J Eur Acad Dermatol Venereol, 21, 421, 10.1111/j.1468-3083.2006.01911.x